Resch et al evaluated the reliability of procalcitonin (PCT), IL-6 and CRP to diagnose early onset neonatal sepsis and found that combining the best performing marker, PCT, with either IL-6 or CRP did not increase the sensitivity for diagnosing sepsis compared to using PCT alone (78). This evidence concerns the gene CRP and Sepsis.